We’ve rebranded some of our products, learn more ›

CODEX® is now PhenoCycler,
Phenoptics™ is now Phenolmager.

All Posts

Interest in these tumor associated macrophages as targets for cancer therapy has grown rapidly in recent years, especially in combination with conventional chemotherapy, radiotherapy, or immunotherapy. Monotherapies targeting TAMs, however, have shown limited evidence of anti-tumor activity. Read about a new study that, by elucidating the landscape of discreet macrophage niches, provides new insights for development of precision-targeted TAM-directed immunotherapies.
AACR meeting, stands as a pinnacle gathering for cancer researchers and healthcare professionals alike. Some see it as an endurance test, others a beacon of innovation, and some a cherished reunion. Yet, it unites everyone in the collective battle against cancer, showcasing progress and relentless dedication. Here’s a quick recap on how cancer researchers have adopted Akoya’s technology in applying spatial biology to cancer medicine.